Cargando…
Formula milk companies push allergy products despite flawed evidence
Europe has toughened its approach to formula milk products that claim to reduce allergy risks. But consumers elsewhere continue to be coaxed into buying products that make health claims without high quality evidence. Melanie Newman reports
Autor principal: | Newman, Melanie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9879268/ https://www.ncbi.nlm.nih.gov/pubmed/35296503 http://dx.doi.org/10.1136/bmj.o630 |
Ejemplares similares
-
Pushing big science frontiers in China
por: Xin, Ling
Publicado: (2023) -
Traditional Approaches for Company Valuation Are Flawed for Valuing In Vivo Gene Therapy Companies
por: Amusa, Gbolahan, et al.
Publicado: (2018) -
Impact of heat stress on milk and meat production
por: Summer, Andrea, et al.
Publicado: (2018) -
Feeding of cows’ milk formula at maternity hospital and the development of cows’ milk allergy
por: Mazzoleni, Stefano
Publicado: (2011) -
Personalized Medicine: Challenging Pharmaceutical and Diagnostic Company Business Models
por: Ferrara, Joseph
Publicado: (2007)